Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts.
Daniele BosoMartina TognonMatteo CurtarelloSonia MinuzzoIlaria PigaValentina BrilloElisabetta LazzariniJessica CarletLudovica MarraChiara TrentoAndrea RasolaIonica MasgrasLeonardo CaporaliFabio Del BenGiulia BrisottoMatteo TurettaRoberta PastorelliLaura BrunelliFilippo NavagliaGiovanni EspositoAngela GrassiStefano IndraccoloPublished in: Journal of experimental & clinical cancer research : CR (2023)
A glucose-deprivation resistant population of ovarian cancer cells showing druggable OXPHOS-dependent metabolic traits is enriched in experimental tumors treated by anti-VEGF therapy.